Go Pro
OTCMKTS:ECIA

Encision Q4 2025 Earnings Report

$0.01 0.00 (0.00%)
As of 10/2/2026

Encision EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Encision Revenue Results

Actual Revenue
$1.58 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Encision Announcement Details

Quarter
Q4 2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Encision Earnings Headlines

Encision Inc Stock Price History
Encision Inc.
The case for $20,000 gold before year end
President Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and America's $40 trillion national debt to a potential surge in gold prices, with some forecasts pointing to $10,000 or even $20,000 gold. Dr. David Eifrig, a 40-year market veteran and former Goldman Sachs Vice President, says an unusual plan involving Trump and two other top officials could fuel the biggest gold bull run in decades. Eifrig has shared his top gold pick tied to this developing story.tc pixel
Encision, Inc.: Encision Deregisters Common Stock
See More Encision Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Encision? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Encision and other key companies, straight to your email.

About Encision

Encision (OTCMKTS:ECIA), Inc. is a medical device company headquartered in Boulder, Colorado. The company develops, manufactures and markets surgical products designed to improve the safety of minimally invasive procedures, particularly those involving electrosurgery.

Encision’s principal technology is Active Electrode Monitoring (AEM), which is intended to detect and reduce unintended electrosurgical energy that can cause damage to surrounding tissue. Its product portfolio includes AEM-enabled laparoscopic instruments and related surgical accessories used in procedures such as general, gynecological and urological surgery.

Founded in 1991, Encision markets its products primarily to hospitals and surgical providers through direct and distribution channels. The company’s offerings are designed for use by surgeons and operating-room professionals seeking enhanced protection against stray energy during laparoscopic procedures.

View Encision Profile